Global Medical Antifungal Agent Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 113

Published Date: 25 May 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Medical Antifungal Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Medical Antifungal Agent market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Dermatophytosis accounting for % of the Medical Antifungal Agent global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Azoles segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Medical Antifungal Agent include Novartis, Pfizer, Bayer, Sanofi, and Merck & Co, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Medical Antifungal Agent market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Azoles
    Echinocandins
    Polyenes
    Allylamines
    Others

Market segment by Application can be divided into
    Dermatophytosis
    Aspergillosis
    Candidiasis
    Others

The key market players for global Medical Antifungal Agent market are listed below:
    Novartis
    Pfizer
    Bayer
    Sanofi
    Merck & Co
    GlaxoSmithKline
    MSD Manuals
    Abbott
    Glenmark
    Enzon Pharmaceuticals
    Astellas Pharma
    Scynexis
    Cidara Therapeutics
    Lucigen Corporation
    Biosergen
    F2G
    Sichuan Meidakang Pharmaceutical
    Chengdu Taihe Health Technology

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Antifungal Agent product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Medical Antifungal Agent, with price, sales, revenue and global market share of Medical Antifungal Agent from 2019 to 2022.
Chapter 3, the Medical Antifungal Agent competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Antifungal Agent breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Medical Antifungal Agent market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Medical Antifungal Agent.
Chapter 13, 14, and 15, to describe Medical Antifungal Agent sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Medical Antifungal Agent Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Medical Antifungal Agent Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Azoles
        1.2.3 Echinocandins
        1.2.4 Polyenes
        1.2.5 Allylamines
        1.2.6 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Medical Antifungal Agent Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Dermatophytosis
        1.3.3 Aspergillosis
        1.3.4 Candidiasis
        1.3.5 Others
    1.4 Global Medical Antifungal Agent Market Size & Forecast
        1.4.1 Global Medical Antifungal Agent Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Medical Antifungal Agent Sales in Volume (2017-2028)
        1.4.3 Global Medical Antifungal Agent Price (2017-2028)
    1.5 Global Medical Antifungal Agent Production Capacity Analysis
        1.5.1 Global Medical Antifungal Agent Total Production Capacity (2017-2028)
        1.5.2 Global Medical Antifungal Agent Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Medical Antifungal Agent Market Drivers
        1.6.2 Medical Antifungal Agent Market Restraints
        1.6.3 Medical Antifungal Agent Trends Analysis

2 Manufacturers Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Medical Antifungal Agent Product and Services
        2.1.4 Novartis Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Pfizer
        2.2.1 Pfizer Details
        2.2.2 Pfizer Major Business
        2.2.3 Pfizer Medical Antifungal Agent Product and Services
        2.2.4 Pfizer Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Bayer
        2.3.1 Bayer Details
        2.3.2 Bayer Major Business
        2.3.3 Bayer Medical Antifungal Agent Product and Services
        2.3.4 Bayer Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Sanofi
        2.4.1 Sanofi Details
        2.4.2 Sanofi Major Business
        2.4.3 Sanofi Medical Antifungal Agent Product and Services
        2.4.4 Sanofi Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Merck & Co
        2.5.1 Merck & Co Details
        2.5.2 Merck & Co Major Business
        2.5.3 Merck & Co Medical Antifungal Agent Product and Services
        2.5.4 Merck & Co Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 GlaxoSmithKline
        2.6.1 GlaxoSmithKline Details
        2.6.2 GlaxoSmithKline Major Business
        2.6.3 GlaxoSmithKline Medical Antifungal Agent Product and Services
        2.6.4 GlaxoSmithKline Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 MSD Manuals
        2.7.1 MSD Manuals Details
        2.7.2 MSD Manuals Major Business
        2.7.3 MSD Manuals Medical Antifungal Agent Product and Services
        2.7.4 MSD Manuals Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Abbott
        2.8.1 Abbott Details
        2.8.2 Abbott Major Business
        2.8.3 Abbott Medical Antifungal Agent Product and Services
        2.8.4 Abbott Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Glenmark
        2.9.1 Glenmark Details
        2.9.2 Glenmark Major Business
        2.9.3 Glenmark Medical Antifungal Agent Product and Services
        2.9.4 Glenmark Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Enzon Pharmaceuticals
        2.10.1 Enzon Pharmaceuticals Details
        2.10.2 Enzon Pharmaceuticals Major Business
        2.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Product and Services
        2.10.4 Enzon Pharmaceuticals Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Astellas Pharma
        2.11.1 Astellas Pharma Details
        2.11.2 Astellas Pharma Major Business
        2.11.3 Astellas Pharma Medical Antifungal Agent Product and Services
        2.11.4 Astellas Pharma Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Scynexis
        2.12.1 Scynexis Details
        2.12.2 Scynexis Major Business
        2.12.3 Scynexis Medical Antifungal Agent Product and Services
        2.12.4 Scynexis Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Cidara Therapeutics
        2.13.1 Cidara Therapeutics Details
        2.13.2 Cidara Therapeutics Major Business
        2.13.3 Cidara Therapeutics Medical Antifungal Agent Product and Services
        2.13.4 Cidara Therapeutics Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Lucigen Corporation
        2.14.1 Lucigen Corporation Details
        2.14.2 Lucigen Corporation Major Business
        2.14.3 Lucigen Corporation Medical Antifungal Agent Product and Services
        2.14.4 Lucigen Corporation Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Biosergen
        2.15.1 Biosergen Details
        2.15.2 Biosergen Major Business
        2.15.3 Biosergen Medical Antifungal Agent Product and Services
        2.15.4 Biosergen Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 F2G
        2.16.1 F2G Details
        2.16.2 F2G Major Business
        2.16.3 F2G Medical Antifungal Agent Product and Services
        2.16.4 F2G Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Sichuan Meidakang Pharmaceutical
        2.17.1 Sichuan Meidakang Pharmaceutical Details
        2.17.2 Sichuan Meidakang Pharmaceutical Major Business
        2.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product and Services
        2.17.4 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.18 Chengdu Taihe Health Technology
        2.18.1 Chengdu Taihe Health Technology Details
        2.18.2 Chengdu Taihe Health Technology Major Business
        2.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Product and Services
        2.18.4 Chengdu Taihe Health Technology Medical Antifungal Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Medical Antifungal Agent Breakdown Data by Manufacturer
    3.1 Global Medical Antifungal Agent Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Medical Antifungal Agent Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Medical Antifungal Agent
    3.4 Market Concentration Rate
        3.4.1 Top 3 Medical Antifungal Agent Manufacturer Market Share in 2021
        3.4.2 Top 6 Medical Antifungal Agent Manufacturer Market Share in 2021
    3.5 Global Medical Antifungal Agent Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Medical Antifungal Agent Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Medical Antifungal Agent Market Size by Region
        4.1.1 Global Medical Antifungal Agent Sales in Volume by Region (2017-2028)
        4.1.2 Global Medical Antifungal Agent Revenue by Region (2017-2028)
    4.2 North America Medical Antifungal Agent Revenue (2017-2028)
    4.3 Europe Medical Antifungal Agent Revenue (2017-2028)
    4.4 Asia-Pacific Medical Antifungal Agent Revenue (2017-2028)
    4.5 South America Medical Antifungal Agent Revenue (2017-2028)
    4.6 Middle East and Africa Medical Antifungal Agent Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Medical Antifungal Agent Sales in Volume by Type (2017-2028)
    5.2 Global Medical Antifungal Agent Revenue by Type (2017-2028)
    5.3 Global Medical Antifungal Agent Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Medical Antifungal Agent Sales in Volume by Application (2017-2028)
    6.2 Global Medical Antifungal Agent Revenue by Application (2017-2028)
    6.3 Global Medical Antifungal Agent Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Medical Antifungal Agent Sales by Type (2017-2028)
    7.2 North America Medical Antifungal Agent Sales by Application (2017-2028)
    7.3 North America Medical Antifungal Agent Market Size by Country
        7.3.1 North America Medical Antifungal Agent Sales in Volume by Country (2017-2028)
        7.3.2 North America Medical Antifungal Agent Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Medical Antifungal Agent Sales by Type (2017-2028)
    8.2 Europe Medical Antifungal Agent Sales by Application (2017-2028)
    8.3 Europe Medical Antifungal Agent Market Size by Country
        8.3.1 Europe Medical Antifungal Agent Sales in Volume by Country (2017-2028)
        8.3.2 Europe Medical Antifungal Agent Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Medical Antifungal Agent Sales by Type (2017-2028)
    9.2 Asia-Pacific Medical Antifungal Agent Sales by Application (2017-2028)
    9.3 Asia-Pacific Medical Antifungal Agent Market Size by Region
        9.3.1 Asia-Pacific Medical Antifungal Agent Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Medical Antifungal Agent Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Medical Antifungal Agent Sales by Type (2017-2028)
    10.2 South America Medical Antifungal Agent Sales by Application (2017-2028)
    10.3 South America Medical Antifungal Agent Market Size by Country
        10.3.1 South America Medical Antifungal Agent Sales in Volume by Country (2017-2028)
        10.3.2 South America Medical Antifungal Agent Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Medical Antifungal Agent Sales by Type (2017-2028)
    11.2 Middle East & Africa Medical Antifungal Agent Sales by Application (2017-2028)
    11.3 Middle East & Africa Medical Antifungal Agent Market Size by Country
        11.3.1 Middle East & Africa Medical Antifungal Agent Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Medical Antifungal Agent Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Medical Antifungal Agent and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Medical Antifungal Agent
    12.3 Medical Antifungal Agent Production Process
    12.4 Medical Antifungal Agent Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Medical Antifungal Agent Typical Distributors
    13.3 Medical Antifungal Agent Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Medical Antifungal Agent Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Medical Antifungal Agent Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Novartis Basic Information, Manufacturing Base and Competitors
    Table 4. Novartis Major Business
    Table 5. Novartis Medical Antifungal Agent Product and Services
    Table 6. Novartis Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 8. Pfizer Major Business
    Table 9. Pfizer Medical Antifungal Agent Product and Services
    Table 10. Pfizer Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Bayer Basic Information, Manufacturing Base and Competitors
    Table 12. Bayer Major Business
    Table 13. Bayer Medical Antifungal Agent Product and Services
    Table 14. Bayer Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 16. Sanofi Major Business
    Table 17. Sanofi Medical Antifungal Agent Product and Services
    Table 18. Sanofi Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Merck & Co Basic Information, Manufacturing Base and Competitors
    Table 20. Merck & Co Major Business
    Table 21. Merck & Co Medical Antifungal Agent Product and Services
    Table 22. Merck & Co Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 24. GlaxoSmithKline Major Business
    Table 25. GlaxoSmithKline Medical Antifungal Agent Product and Services
    Table 26. GlaxoSmithKline Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. MSD Manuals Basic Information, Manufacturing Base and Competitors
    Table 28. MSD Manuals Major Business
    Table 29. MSD Manuals Medical Antifungal Agent Product and Services
    Table 30. MSD Manuals Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Abbott Basic Information, Manufacturing Base and Competitors
    Table 32. Abbott Major Business
    Table 33. Abbott Medical Antifungal Agent Product and Services
    Table 34. Abbott Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Glenmark Basic Information, Manufacturing Base and Competitors
    Table 36. Glenmark Major Business
    Table 37. Glenmark Medical Antifungal Agent Product and Services
    Table 38. Glenmark Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Enzon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 40. Enzon Pharmaceuticals Major Business
    Table 41. Enzon Pharmaceuticals Medical Antifungal Agent Product and Services
    Table 42. Enzon Pharmaceuticals Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Astellas Pharma Basic Information, Manufacturing Base and Competitors
    Table 44. Astellas Pharma Major Business
    Table 45. Astellas Pharma Medical Antifungal Agent Product and Services
    Table 46. Astellas Pharma Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. Scynexis Basic Information, Manufacturing Base and Competitors
    Table 48. Scynexis Major Business
    Table 49. Scynexis Medical Antifungal Agent Product and Services
    Table 50. Scynexis Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 51. Cidara Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 52. Cidara Therapeutics Major Business
    Table 53. Cidara Therapeutics Medical Antifungal Agent Product and Services
    Table 54. Cidara Therapeutics Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 55. Lucigen Corporation Basic Information, Manufacturing Base and Competitors
    Table 56. Lucigen Corporation Major Business
    Table 57. Lucigen Corporation Medical Antifungal Agent Product and Services
    Table 58. Lucigen Corporation Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 59. Biosergen Basic Information, Manufacturing Base and Competitors
    Table 60. Biosergen Major Business
    Table 61. Biosergen Medical Antifungal Agent Product and Services
    Table 62. Biosergen Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 63. F2G Basic Information, Manufacturing Base and Competitors
    Table 64. F2G Major Business
    Table 65. F2G Medical Antifungal Agent Product and Services
    Table 66. F2G Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 67. Sichuan Meidakang Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 68. Sichuan Meidakang Pharmaceutical Major Business
    Table 69. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product and Services
    Table 70. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 71. Chengdu Taihe Health Technology Basic Information, Manufacturing Base and Competitors
    Table 72. Chengdu Taihe Health Technology Major Business
    Table 73. Chengdu Taihe Health Technology Medical Antifungal Agent Product and Services
    Table 74. Chengdu Taihe Health Technology Medical Antifungal Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 75. Global Medical Antifungal Agent Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
    Table 76. Global Medical Antifungal Agent Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 77. Market Position of Manufacturers in Medical Antifungal Agent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 78. Global Medical Antifungal Agent Production Capacity by Company, (K Units): 2020 VS 2021
    Table 79. Head Office and Medical Antifungal Agent Production Site of Key Manufacturer
    Table 80. Medical Antifungal Agent New Entrant and Capacity Expansion Plans
    Table 81. Medical Antifungal Agent Mergers & Acquisitions in the Past Five Years
    Table 82. Global Medical Antifungal Agent Sales by Region (2017-2022) & (K Units)
    Table 83. Global Medical Antifungal Agent Sales by Region (2023-2028) & (K Units)
    Table 84. Global Medical Antifungal Agent Revenue by Region (2017-2022) & (USD Million)
    Table 85. Global Medical Antifungal Agent Revenue by Region (2023-2028) & (USD Million)
    Table 86. Global Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
    Table 87. Global Medical Antifungal Agent Sales by Type (2023-2028) & (K Units)
    Table 88. Global Medical Antifungal Agent Revenue by Type (2017-2022) & (USD Million)
    Table 89. Global Medical Antifungal Agent Revenue by Type (2023-2028) & (USD Million)
    Table 90. Global Medical Antifungal Agent Price by Type (2017-2022) & (US$/Unit)
    Table 91. Global Medical Antifungal Agent Price by Type (2023-2028) & (US$/Unit)
    Table 92. Global Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
    Table 93. Global Medical Antifungal Agent Sales by Application (2023-2028) & (K Units)
    Table 94. Global Medical Antifungal Agent Revenue by Application (2017-2022) & (USD Million)
    Table 95. Global Medical Antifungal Agent Revenue by Application (2023-2028) & (USD Million)
    Table 96. Global Medical Antifungal Agent Price by Application (2017-2022) & (US$/Unit)
    Table 97. Global Medical Antifungal Agent Price by Application (2023-2028) & (US$/Unit)
    Table 98. North America Medical Antifungal Agent Sales by Country (2017-2022) & (K Units)
    Table 99. North America Medical Antifungal Agent Sales by Country (2023-2028) & (K Units)
    Table 100. North America Medical Antifungal Agent Revenue by Country (2017-2022) & (USD Million)
    Table 101. North America Medical Antifungal Agent Revenue by Country (2023-2028) & (USD Million)
    Table 102. North America Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
    Table 103. North America Medical Antifungal Agent Sales by Type (2023-2028) & (K Units)
    Table 104. North America Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
    Table 105. North America Medical Antifungal Agent Sales by Application (2023-2028) & (K Units)
    Table 106. Europe Medical Antifungal Agent Sales by Country (2017-2022) & (K Units)
    Table 107. Europe Medical Antifungal Agent Sales by Country (2023-2028) & (K Units)
    Table 108. Europe Medical Antifungal Agent Revenue by Country (2017-2022) & (USD Million)
    Table 109. Europe Medical Antifungal Agent Revenue by Country (2023-2028) & (USD Million)
    Table 110. Europe Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
    Table 111. Europe Medical Antifungal Agent Sales by Type (2023-2028) & (K Units)
    Table 112. Europe Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
    Table 113. Europe Medical Antifungal Agent Sales by Application (2023-2028) & (K Units)
    Table 114. Asia-Pacific Medical Antifungal Agent Sales by Region (2017-2022) & (K Units)
    Table 115. Asia-Pacific Medical Antifungal Agent Sales by Region (2023-2028) & (K Units)
    Table 116. Asia-Pacific Medical Antifungal Agent Revenue by Region (2017-2022) & (USD Million)
    Table 117. Asia-Pacific Medical Antifungal Agent Revenue by Region (2023-2028) & (USD Million)
    Table 118. Asia-Pacific Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
    Table 119. Asia-Pacific Medical Antifungal Agent Sales by Type (2023-2028) & (K Units)
    Table 120. Asia-Pacific Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
    Table 121. Asia-Pacific Medical Antifungal Agent Sales by Application (2023-2028) & (K Units)
    Table 122. South America Medical Antifungal Agent Sales by Country (2017-2022) & (K Units)
    Table 123. South America Medical Antifungal Agent Sales by Country (2023-2028) & (K Units)
    Table 124. South America Medical Antifungal Agent Revenue by Country (2017-2022) & (USD Million)
    Table 125. South America Medical Antifungal Agent Revenue by Country (2023-2028) & (USD Million)
    Table 126. South America Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
    Table 127. South America Medical Antifungal Agent Sales by Type (2023-2028) & (K Units)
    Table 128. South America Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
    Table 129. South America Medical Antifungal Agent Sales by Application (2023-2028) & (K Units)
    Table 130. Middle East & Africa Medical Antifungal Agent Sales by Region (2017-2022) & (K Units)
    Table 131. Middle East & Africa Medical Antifungal Agent Sales by Region (2023-2028) & (K Units)
    Table 132. Middle East & Africa Medical Antifungal Agent Revenue by Region (2017-2022) & (USD Million)
    Table 133. Middle East & Africa Medical Antifungal Agent Revenue by Region (2023-2028) & (USD Million)
    Table 134. Middle East & Africa Medical Antifungal Agent Sales by Type (2017-2022) & (K Units)
    Table 135. Middle East & Africa Medical Antifungal Agent Sales by Type (2023-2028) & (K Units)
    Table 136. Middle East & Africa Medical Antifungal Agent Sales by Application (2017-2022) & (K Units)
    Table 137. Middle East & Africa Medical Antifungal Agent Sales by Application (2023-2028) & (K Units)
    Table 138. Medical Antifungal Agent Raw Material
    Table 139. Key Manufacturers of Medical Antifungal Agent Raw Materials
    Table 140. Direct Channel Pros & Cons
    Table 141. Indirect Channel Pros & Cons
    Table 142. Medical Antifungal Agent Typical Distributors
    Table 143. Medical Antifungal Agent Typical Customers
List of Figures
    Figure 1. Medical Antifungal Agent Picture
    Figure 2. Global Medical Antifungal Agent Revenue Market Share by Type in 2021
    Figure 3. Azoles
    Figure 4. Echinocandins
    Figure 5. Polyenes
    Figure 6. Allylamines
    Figure 7. Others
    Figure 8. Global Medical Antifungal Agent Revenue Market Share by Application in 2021
    Figure 9. Dermatophytosis
    Figure 10. Aspergillosis
    Figure 11. Candidiasis
    Figure 12. Others
    Figure 13. Global Medical Antifungal Agent Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
    Figure 14. Global Medical Antifungal Agent Revenue and Forecast (2017-2028) & (USD Million)
    Figure 15. Global Medical Antifungal Agent Sales (2017-2028) & (K Units)
    Figure 16. Global Medical Antifungal Agent Price (2017-2028) & (US$/Unit)
    Figure 17. Global Medical Antifungal Agent Production Capacity (2017-2028) & (K Units)
    Figure 18. Global Medical Antifungal Agent Production Capacity by Geographic Region: 2022 VS 2028
    Figure 19. Medical Antifungal Agent Market Drivers
    Figure 20. Medical Antifungal Agent Market Restraints
    Figure 21. Medical Antifungal Agent Market Trends
    Figure 22. Global Medical Antifungal Agent Sales Market Share by Manufacturer in 2021
    Figure 23. Global Medical Antifungal Agent Revenue Market Share by Manufacturer in 2021
    Figure 24. Medical Antifungal Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 25. Top 3 Medical Antifungal Agent Manufacturer (Revenue) Market Share in 2021
    Figure 26. Top 6 Medical Antifungal Agent Manufacturer (Revenue) Market Share in 2021
    Figure 27. Global Medical Antifungal Agent Sales Market Share by Region (2017-2028)
    Figure 28. Global Medical Antifungal Agent Revenue Market Share by Region (2017-2028)
    Figure 29. North America Medical Antifungal Agent Revenue (2017-2028) & (USD Million)
    Figure 30. Europe Medical Antifungal Agent Revenue (2017-2028) & (USD Million)
    Figure 31. Asia-Pacific Medical Antifungal Agent Revenue (2017-2028) & (USD Million)
    Figure 32. South America Medical Antifungal Agent Revenue (2017-2028) & (USD Million)
    Figure 33. Middle East & Africa Medical Antifungal Agent Revenue (2017-2028) & (USD Million)
    Figure 34. Global Medical Antifungal Agent Sales Market Share by Type (2017-2028)
    Figure 35. Global Medical Antifungal Agent Revenue Market Share by Type (2017-2028)
    Figure 36. Global Medical Antifungal Agent Price by Type (2017-2028) & (US$/Unit)
    Figure 37. Global Medical Antifungal Agent Sales Market Share by Application (2017-2028)
    Figure 38. Global Medical Antifungal Agent Revenue Market Share by Application (2017-2028)
    Figure 39. Global Medical Antifungal Agent Price by Application (2017-2028) & (US$/Unit)
    Figure 40. North America Medical Antifungal Agent Sales Market Share by Type (2017-2028)
    Figure 41. North America Medical Antifungal Agent Sales Market Share by Application (2017-2028)
    Figure 42. North America Medical Antifungal Agent Sales Market Share by Country (2017-2028)
    Figure 43. North America Medical Antifungal Agent Revenue Market Share by Country (2017-2028)
    Figure 44. United States Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 45. Canada Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 46. Mexico Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 47. Europe Medical Antifungal Agent Sales Market Share by Type (2017-2028)
    Figure 48. Europe Medical Antifungal Agent Sales Market Share by Application (2017-2028)
    Figure 49. Europe Medical Antifungal Agent Sales Market Share by Country (2017-2028)
    Figure 50. Europe Medical Antifungal Agent Revenue Market Share by Country (2017-2028)
    Figure 51. Germany Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. France Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. United Kingdom Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Russia Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Italy Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Asia-Pacific Medical Antifungal Agent Sales Market Share by Region (2017-2028)
    Figure 57. Asia-Pacific Medical Antifungal Agent Sales Market Share by Application (2017-2028)
    Figure 58. Asia-Pacific Medical Antifungal Agent Sales Market Share by Region (2017-2028)
    Figure 59. Asia-Pacific Medical Antifungal Agent Revenue Market Share by Region (2017-2028)
    Figure 60. China Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Japan Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Korea Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. India Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Southeast Asia Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Australia Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. South America Medical Antifungal Agent Sales Market Share by Type (2017-2028)
    Figure 67. South America Medical Antifungal Agent Sales Market Share by Application (2017-2028)
    Figure 68. South America Medical Antifungal Agent Sales Market Share by Country (2017-2028)
    Figure 69. South America Medical Antifungal Agent Revenue Market Share by Country (2017-2028)
    Figure 70. Brazil Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Argentina Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Middle East & Africa Medical Antifungal Agent Sales Market Share by Type (2017-2028)
    Figure 73. Middle East & Africa Medical Antifungal Agent Sales Market Share by Application (2017-2028)
    Figure 74. Middle East & Africa Medical Antifungal Agent Sales Market Share by Region (2017-2028)
    Figure 75. Middle East & Africa Medical Antifungal Agent Revenue Market Share by Region (2017-2028)
    Figure 76. Turkey Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Egypt Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Saudi Arabia Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 79. South Africa Medical Antifungal Agent Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 80. Manufacturing Cost Structure Analysis of Medical Antifungal Agent in 2021
    Figure 81. Manufacturing Process Analysis of Medical Antifungal Agent
    Figure 82. Medical Antifungal Agent Industrial Chain
    Figure 83. Sales Channel: Direct Channel vs Indirect Channel
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
Pfizer
Bayer
Sanofi
Merck & Co
GlaxoSmithKline
MSD Manuals
Abbott
Glenmark
Enzon Pharmaceuticals
Astellas Pharma
Scynexis
Cidara Therapeutics
Lucigen Corporation
Biosergen
F2G
Sichuan Meidakang Pharmaceutical
Chengdu Taihe Health Technology

Related Reports

Global Medical Antifungal Agent Supply, Demand and Key Producers, 2023-2029

Global Medical Antifungal Agent Supply, Demand and Key Producers, 2023-2029

date 05 Sep 2023

date Pharma & Healthcare

The global Medical Antifungal Agent market size is expected to reach $ 16240 million by 2029, rising at a market growth of 2.8% CAGR during the forecast period (2023-2029).

Global Medical Antifungal Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Medical Antifungal Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 05 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medical Antifungal Agent market size was valued at USD 13400 million in 2022 and is forecast to a readjusted size of USD 16240 million by 2029 with a CAGR of 2.8% during review period.

Global Medical Antifungal Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Medical Antifungal Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 14 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medical Antifungal Agent market size was valued at USD 13400 million in 2023 and is forecast to a readjusted size of USD 16240 million by 2030 with a CAGR of 2.8% during review period.

Product Tags

medical antifungal agent

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>